A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Hyperfine, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 1,100 shares of HYPR stock, worth $979. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,100
Previous 900 22.22%
Holding current value
$979
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.9 - $1.24 $28,235 - $38,902
-31,373 Reduced 71.25%
12,662 $13,000
Q2 2024

Aug 14, 2024

SELL
$0.79 - $1.02 $8,763 - $11,314
-11,093 Reduced 20.12%
44,035 $37,000
Q1 2024

May 15, 2024

SELL
$0.96 - $1.25 $86,821 - $113,048
-90,439 Reduced 62.13%
55,128 $55,000
Q4 2023

Feb 14, 2024

BUY
$1.03 - $1.99 $149,934 - $289,678
145,567 New
145,567 $163,000
Q3 2022

Nov 14, 2022

BUY
$0.81 - $2.06 $56,747 - $144,321
70,059 New
70,059 $57,000

Others Institutions Holding HYPR

About Hyperfine, Inc.


  • Ticker HYPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,515,500
  • Market Cap $49.4M
  • Description
  • Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.
More about HYPR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.